Remedy reports revenue declines in Q2 and H1 as it prepares for Control Resonant launch
Covered by 1 source · 1 article
In this story
Remedy reported revenue declines in the first half and second quarter of 2026 while increasing marketing efforts for Control Resonant. Read more
Covered by
